Trigeminal neuralgia: a nerve under pressure, and a brain that can turn the volume up.

The jolts are among the worst pain known. Some of that intensity comes from the nerve, and some from how a sensitized brain processes it.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

Getting the diagnosis right

Trigeminal neuralgia, once called tic douloureux, is a disorder of the trigeminal nerve, the large nerve that carries sensation from the face. Classic attacks are brief, electric, stabbing jolts on one side of the face, triggered by light touch, chewing, talking, cold wind or brushing the teeth. Between attacks there may be nothing, or a duller background ache.

The most common cause is a small artery or vein pressing on the nerve where it leaves the brainstem, which wears away the nerve's insulation. Multiple sclerosis can cause it by damaging the same area, and rarely a tumour is responsible. For these reasons an MRI is part of the standard workup, and the first task is always to find and treat any structural cause. Medications that stabilise nerve firing, especially carbamazepine, help most people, and surgical options exist when they do not.

The ATNS index does not dispute any of this. It asks that the assessment also include the nervous system's own contribution, because a nerve under pressure does not explain everything that people with trigeminal neuralgia experience.

The neuroplastic contribution

Neuroplastic symptoms are real physical symptoms produced by learned pathways in the brain and nervous system, a sensitized alarm system, rather than by ongoing damage or disease. They are not imaginary, and because the brain can change, they are reversible.

The ATNS Index of Neuroplastic Symptoms says that in trigeminal neuralgia an evaluation for neuroplastic symptoms should be done as part of a complete assessment, particularly if the symptoms or clinical course over time are not typical, or if the response to treatment is not as expected. In practice that covers a lot of people:

• Atypical features. Constant burning or aching rather than brief jolts, pain on both sides, pain spreading beyond the nerve's territory, or pain that began after a stressful period rather than with any identifiable cause.
• Treatment that does not fit. Pain that persists after a successful decompression surgery with a clean MRI, or that fluctuates independently of medication dose.
• Fear as fuel. Dread of the next jolt leads to guarding the face, avoiding eating, talking and touch, and constant vigilance. That threat state lowers the brain's threshold for pain, the mechanism described in central sensitization.
• Mood and sleep. Depression, anxiety and broken sleep are common and each one turns up the pain signal.

Even when a vessel is clearly pressing on the nerve, the brain decides how loud the signal becomes. That is why two people with similar MRI findings can have very different lives.

What the research shows

A 2022 review of the molecular basis and pathophysiology of trigeminal neuralgia describes central sensitization, a state of nervous-system hyperexcitability, as a contributor alongside nerve compression, and proposes that sensitized trigeminal pathways and the brain's descending pain-control circuits both shape the condition.

A brain imaging study of pain and emotion networks in trigeminal neuralgia found altered connectivity in circuits that process both pain and emotion, and noted that clinical depression and anxiety in people with the condition are roughly three times as common as in matched controls, which is consistent with a shared neural basis rather than mood simply reacting to pain.

A nationwide population-based cohort study examined the risk of psychiatric disorders following a diagnosis of trigeminal neuralgia, documenting the elevated rates of depression and anxiety that follow the condition.

A multicentre case-controlled study across neurological, psychiatric and pain disorders found that central sensitization symptoms were associated with pain severity and depressive symptoms, and suggested sensitization as a shared treatment target. That study was not specific to trigeminal neuralgia, so it supports the general principle rather than a condition-specific claim.

Signs the brain may be part of the picture

• Constant burning or aching pain rather than, or in addition to, brief electric jolts.
• Pain that has spread beyond one nerve branch, crossed to the other side, or moved into the neck, scalp or jaw.
• Pain that persists after decompression surgery despite good imaging results.
• Flares that follow stress, conflict or poor sleep more than any physical trigger.
• Fear of eating, speaking or touching the face that has reshaped your daily life.

A solution that addresses it

Alongside neurological care, there is an approach that addresses the brain's contribution. Pain and symptom reprocessing includes education about neuroplastic symptoms and how the brain sets the pain volume, somatic tracking of background facial sensations with curiosity instead of dread, reducing fear and guarding, a graded return to eating, speaking and touch, emotional awareness and expression, and acceptance and commitment skills for living fully with a condition that may need ongoing medical treatment. Trained clinicians deliver it, and digital programs increasingly make it available every day. It complements medication and surgery; it does not replace them.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If fear and sensitization have become part of your facial pain, join the waitlist.

What to do next

See a neurologist and complete the structural workup, including MRI, to identify vascular compression, multiple sclerosis or a tumour. Take medication as prescribed and never stop it abruptly; carbamazepine and similar drugs need careful adjustment. Seek prompt attention for new numbness, weakness, hearing loss, double vision, or a change in the pattern of pain, which can signal a structural change.

Then ask whether parts of your pain are atypical, or whether treatment has not worked as expected. If so, ask about a neuroplastic assessment and start learning and practising. Our article on hurt versus harm is a good place to begin: a trigeminal jolt is terrifying, but it is not damaging your face.

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.